Authors: UNTCH M SEVIN BU PERRAS JP ANGIOLI R UNTCH A HIGHTOWER RD KOECHLI O AVERETTE HE

Citation: M. Untch et al., EVALUATION OF PACLITAXEL (TAXOL), CISPLATIN, AND THE COMBINATION PACLITAXEL-CISPLATIN IN OVARIAN-CANCER IN-VITRO WITH THE ATP CELL VIABILITY ASSAY, Gynecologic oncology, 53(1), 1994, pp. 44-49

Authors: HIGHTOWER RD NGUYEN HN AVERETTE HE HOSKINS W HARRISON T STEREN A

Citation: Rd. Hightower et al., NATIONAL SURVEY OF OVARIAN-CARCINOMA .4. PATTERNS OF CARE AND RELATEDSURVIVAL FOR OLDER PATIENTS, Cancer, 73(2), 1994, pp. 377-383

Authors: HIGHTOWER RD SEVIN BU PERRAS J NGUYEN H ANGIOLI R UNTCH M AVERETTE H

Citation: Rd. Hightower et al., INVITRO EVALUATION OF THE NOVEL CHEMOTHERAPEUTIC-AGENTS U-73,975, U-77,779, AND U-80,244 IN GYNECOLOGIC CANCER CELL-LINES, Cancer investigation, 11(3), 1993, pp. 276-282

Authors: ANGIOLI R UNTCH M SEVIN BU STEREN A HIGHTOWER RD PERRAS JP NGUYEN HN KOECHLI OR AVERETTE HE

Citation: R. Angioli et al., ENHANCEMENT OF PROGESTERONE-RECEPTOR LEVELS BY INTERFERONS IN AE-7 ENDOMETRIAL CANCER-CELLS, Cancer, 71(9), 1993, pp. 2776-2781